CH450416A - Verfahren zur Herstellung von halogenierten Indolylessigsäurederivaten - Google Patents

Verfahren zur Herstellung von halogenierten Indolylessigsäurederivaten

Info

Publication number
CH450416A
CH450416A CH1075363A CH1075363A CH450416A CH 450416 A CH450416 A CH 450416A CH 1075363 A CH1075363 A CH 1075363A CH 1075363 A CH1075363 A CH 1075363A CH 450416 A CH450416 A CH 450416A
Authority
CH
Switzerland
Prior art keywords
halogenated
preparation
acid derivatives
indolylacetic acid
indolylacetic
Prior art date
Application number
CH1075363A
Other languages
English (en)
Inventor
Shen Tsung-Ying
Hastings Sarett Lewis
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH450416A publication Critical patent/CH450416A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1075363A 1962-09-07 1963-08-30 Verfahren zur Herstellung von halogenierten Indolylessigsäurederivaten CH450416A (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US222179A US3259622A (en) 1962-09-07 1962-09-07 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
US45201865A 1965-04-29 1965-04-29
US452015A US3399198A (en) 1962-09-07 1965-04-29 1-pyrimidinoyl-and 1-imidazoloyl-3-haloacetyl indoles
US452010A US3388127A (en) 1962-09-07 1965-04-29 Alpha-halomethyl-1-pyrazine carbonyl-3-indolylacetic acids
US452022A US3326930A (en) 1962-09-07 1965-04-29 alpha-halomethyl-(1-oxazole-carbonylindol-3-yl) acetic acids and certain intermediates therefor

Publications (1)

Publication Number Publication Date
CH450416A true CH450416A (de) 1968-01-31

Family

ID=27539838

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1075363A CH450416A (de) 1962-09-07 1963-08-30 Verfahren zur Herstellung von halogenierten Indolylessigsäurederivaten

Country Status (10)

Country Link
US (5) US3259622A (de)
AT (2) AT263765B (de)
BE (2) BE637036A (de)
CH (1) CH450416A (de)
DE (1) DE1470045A1 (de)
DK (1) DK120898B (de)
FR (3) FR1535407A (de)
GB (6) GB1063385A (de)
NL (2) NL297644A (de)
SE (1) SE309040B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929820A (en) * 1967-09-26 1975-12-30 Bayer Ag Process for the production of N-tritylimidazoles
JPS5683472A (en) * 1979-12-12 1981-07-08 Teijin Ltd Preparation of 3-acyl-1-substituted indole derivative
US4499279A (en) * 1980-04-10 1985-02-12 Sandoz, Inc. Isoxazolyl indolamines
JPS57159738A (en) * 1981-03-30 1982-10-01 Sagami Chem Res Center 2-halomethylene-arylacetice acid derivative
EP0411150B1 (de) * 1989-02-10 1996-11-27 Otsuka Pharmaceutical Co., Ltd. Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
US5166170A (en) * 1989-07-03 1992-11-24 Hoechst-Roussel Pharmaceuticals Incorporated 2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
GB9004301D0 (en) * 1990-02-26 1990-04-18 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
US5283251A (en) * 1990-02-26 1994-02-01 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5064851A (en) * 1990-07-24 1991-11-12 Pfizer Inc. 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
MX9202022A (es) * 1991-05-01 1992-11-01 Otsuka Pharma Co Ltd Derivados de pirazina y proceso para su preparacion.
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
ES2179088T3 (es) * 1994-04-01 2003-01-16 Lilly Co Eli Inhibidores de flsa2 1h-indol-3-glioxilamida.
US5641800A (en) * 1994-07-21 1997-06-24 Eli Lilly And Company 1H-indole-1-functional sPLA2 inhibitors
US6214876B1 (en) 1994-07-21 2001-04-10 Eli Lilly And Company Indene-1-acetamide sPLA2 inhibitors
US5604253A (en) * 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
JP3842043B2 (ja) * 1998-04-28 2006-11-08 エルビオン アクチエンゲゼルシャフト 新規ヒドロキシインドール、ホスホジエステラーゼ４のインヒビタとしてのその使用及びその製法
EP0980863B1 (de) * 1998-08-17 2005-02-02 Givaudan SA Oximcarbonsäure Derivate
ES2235412T3 (es) 1998-08-17 2005-07-01 Givaudan Sa Derivados de oxima de acido carboxilico.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB869775A (en) * 1958-09-24 1961-06-07 Upjohn Co 3-indolyl ketones
US2978459A (en) * 1959-08-05 1961-04-04 Upjohn Co Ketals of (3-indolyl)-aminoalkanones
US3201414A (en) * 1963-07-22 1965-08-17 Merck & Co Inc New 1-heteroacyl-3-indolyl aliphatic acids
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
US3242192A (en) * 1962-09-07 1966-03-22 Merck & Co Inc Alpha-haloalkyl (3-indolyl) acetic acid derivatives

Also Published As

Publication number Publication date
AT262274B (de) 1968-06-10
DK120898B (da) 1971-08-02
GB1048346A (en) 1966-11-16
GB1063384A (en) 1967-03-30
SE309040B (de) 1969-03-10
US3326930A (en) 1967-06-20
FR1535407A (fr) 1968-08-09
US3259622A (en) 1966-07-05
FR3556M (de) 1965-10-22
NL297645A (de) 1965-11-10
GB1063385A (en) 1967-03-30
AT263765B (de) 1968-08-12
BE637037A (de) 1964-03-05
US3426038A (en) 1969-02-04
GB1048347A (en) 1966-11-16
US3388127A (en) 1968-06-11
GB1063383A (en) 1967-03-30
BE637036A (de) 1964-03-05
NL297644A (de) 1965-11-10
US3399198A (en) 1968-08-27
FR3555M (de) 1965-10-22
DE1470045A1 (de) 1969-05-29
GB1049840A (en) 1966-11-30

Similar Documents

Publication Publication Date Title
CH528479A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH455775A (de) Verfahren zur Herstellung von Indolyl-essigsäure-Derivaten
CH450416A (de) Verfahren zur Herstellung von halogenierten Indolylessigsäurederivaten
CH408006A (de) Verfahren zur Herstellung von Chinolyl-(8)-oxyessigsäurederivaten
CH460026A (de) Verfahren zur Herstellung von Pyrazolderivaten
CH485703A (de) Verfahren zur Herstellung von Pyromekonsäurederivaten
CH428767A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanolderivaten
CH445514A (de) Verfahren zur Herstellung von 6-Alkylmorphinan-Derivaten
CH426830A (de) Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-derivaten
AT249860B (de) Verfahren zur Herstellung von α-Aminoacyl-6-aminopenicillansäurederivaten
CH439296A (de) Verfahren zur Herstellung von Phenothiazinderivaten
CH438350A (de) Verfahren zur Herstellung von 6-Hydroxy-morphinan-Derivaten
CH469023A (de) Verfahren zur Herstellung von Derivaten der 7-Aminocephalosporansäure
CH442309A (de) Verfahren zur Herstellung von Derivaten von Cephalosporin C.
AT243794B (de) Verfahren zur Herstellung von Carbostyrilderivaten
AT249858B (de) Verfahren zur Herstellung von 7-Aminocephalosporansäure
CH429739A (de) Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten
CH424760A (de) Verfahren zur Herstellung von Derivaten der Fluor-dichlor-methansulfensäure
CH442349A (de) Verfahren zur Herstellung von Derivaten der a-Tetronsäure
CH481897A (de) Verfahren zur Herstellung von substituierten Essigsäure-Derivaten
CH422002A (de) Verfahren zur Herstellung von Oxytrimesinsäure
AT249669B (de) Verfahren zur Herstellung von Imidazolderivaten
CH461491A (de) Verfahren zur Herstellung von 7-Aminocephalosporansäure-Derivaten
AT225700B (de) Verfahren zur Herstellung von Phenylalkanolaminderivaten
CH451167A (de) Verfahren zur Herstellung von 2-Alkoxycycloheptimidazolderivaten